Sunshine Biopharma SBFM
NASDAQ SBFM
$0.69 -0.09 (-11.05%)
As of: Oct 1, 2026 · 3:59 PM EDT

Sunshine Biopharma (SBFM) Depreciation & Amortization (CF) (2015 - 2026)

Updated

Sunshine Biopharma (SBFM) reported Depreciation & Amortization (CF) of $77,974 for Q2 2026, up 7.6% from $72,443 a year earlier and up 1.5% from the prior quarter.

Analysis

Sunshine Biopharma (SBFM) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Sunshine Biopharma's Depreciation & Amortization (CF) came in at $349,667, up 30.8% year-over-year; for FY2025, it was $332,070, up 48.6% from FY2024.

  • Depreciation & Amortization (CF) has increased for four consecutive years, with a five-year compound annual growth rate of 88.2% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $223,527 in FY2024 (+49.9%), $149,147 in FY2023 (+492.7%), $25,163 in FY2022 (+97.5%) and $12,741 in FY2021 (-9.4%).
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $789.00 in Q3 2022 and a high of $98,581 in Q4 2025.
  • Year over year, Depreciation & Amortization (CF) has now increased in each of the last 11 quarters, with growth averaging 43.6% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q4 2022 (growth of 496.0%); the low point was Q3 2022 (a decline of 75.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $76,859 (Q1 2026), $98,581 (Q4 2025) and $96,253 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Sunshine Biopharma 1.05 Mn -38.04 Mn 2.43 Mn 77,974.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 77,974.00
Mar 31, 2026 76,859.00
Dec 31, 2025 98,581.00
Sep 30, 2025 96,253.00
Jun 30, 2025 72,443.00
Mar 31, 2025 64,793.00
Dec 31, 2024 65,399.00
Sep 30, 2024 64,634.00
Jun 30, 2024 50,876.00
Mar 31, 2024 42,618.00
Dec 31, 2023 42,353.00
Sep 30, 2023 37,200.00
Jun 30, 2023 34,884.00
Mar 31, 2023 34,710.00
Dec 31, 2022 18,977.00
Sep 30, 2022 789.00
Jun 30, 2022 2,287.00
Mar 31, 2022 3,110.00
Dec 31, 2021 3,184.00
Sep 30, 2021 3,183.00
API Access

Sunshine Biopharma Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=SBFM&period=max&api_key=YOUR_API_KEY